# OnCo record paper-nct02152631-front-oncol-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct02152631-front-oncol-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct02152631-front-oncol-2020" ;
  schema:name "A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER"@en ;
  schema:description "Published report from the JUNIPER trial registered as NCT02152631, in Frontiers in oncology (2020), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct02152631-front-oncol-2020/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.3389/fonc.2020.578756>, <https://pubmed.ncbi.nlm.nih.gov/33194700/>, <https://europepmc.org/article/MED/33194700>, <https://clinicaltrials.gov/study/NCT02152631> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.3389/fonc.2020.578756> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Goldman JW, Mazieres J, Barlesi F, et al." ;
  onco:trials <https://onco.cc/trials/nct02152631/> .